Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R21)
The summary for the Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R21) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R21): -Purpose. This funding opportunity announcement (FOA) encourages research applications that propose to develop and validate new mitochondrial-related biomarkers for cancer early detection, diagnosis, prognosis, risk assessment, and response to preventive and ameliorative treatment. -Mechanism of Support. This FOA utilizes the NIH Exploratory/Developmental Grant (R21) mechanism and runs in parallel with an FOA of identical scientific scope, PA-08-143, that solicits applications under the NIH Research Project Grant (R01) mechanism. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications; therefore, the anticipated number of awards is not known. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received
| Federal Grant Title: | Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R21) |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Education Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | PA-08-144 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.39393.394 |
| CFDA Descriptions: | Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research |
| Current Application Deadline: | No deadline provided |
| Original Application Deadline: | May 07, 2011 |
| Posted Date: | Apr 11, 2008 |
| Creation Date: | Apr 11, 2008 |
| Archive Date: | Dec 05, 2008 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | $200,000 |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | 93.395 -- Cancer Treatment Research |
- Applicants Eligible for this Grant
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) State governments Private institutions of higher education Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Non-domestic (non-U.S.) Entities (Foreign Organizations); U.S. Territory or Possession.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster